ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OUST vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Ouster Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: OUST 2 — TMO 8
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OUST VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OUST TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -30.10% 9.30% -39.40 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -2.80% 2.40% -5.20 TMO /fcf-yield <GO>
Operating Margin -43.70% 17.40% -61.10 TMO /operating-margins <GO>
Net Profit Margin -35.60% 15.10% -50.70 TMO /net-margins <GO>
Revenue Growth (YoY) 52.50% 3.90% +48.60 OUST /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.44 4.50 +7.94 OUST /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.8 62.9 -23.08 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.32B $262.22B -$259.90B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OUST REV TMO REV OUST GROSS % TMO GROSS % OUST FCF TMO FCF
FY 2025 $169.4M $44.56B 49.3% — -$64.8M $6.29B
FY 2024 $111.1M $42.88B 36.4% — -$37.5M $7.27B
FY 2023 $83.3M $42.86B — — -$137.9M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OUST // BETA —
TMO // BETA 0.94